New information on opportunistic infections and co-infections.
Many reports have shown fewer opportunistic infections (OIs) and deaths since the wide-scale availability and use of potent anti-HIV therapy. Also, there have been many reports of people stopping preventive therapies for OIs. Now several studies further confirm that it may be safe for some people to stop preventive therapies when their CD4+ cell count increases are sustained over time. In addition, ongoing research into hepatitis co-infection (with HIV) is beginning to show progress.